Heart failure & cardiomyopathies
Serum Proteomic Analysis of Peripartum Cardiomyopathy Reveals Distinctive Dysregulation of Inflammatory and Cholesterol Metabolism Pathways
Authors' conclusion
Serum proteomic profiling of PPCM relative to NPCM and healthy controls indicated that PPCM is a distinct disease entity characterized by the unique dysregulation of inflammation-related pathways and cholesterol metabolism-related anti-inflammatory pathways.
Study context
- Population
- Women with pathophysiology of peripartum cardiomyopathy (PPCM) or nonperipartum cardiomyopathy (NPCM) and healthy peripartum and nonperipartum women; serum from the IPAC and IMAC2 studies
- Participants
- 67 / 31 / 10 / 10
- Comparison
- PPCM vs NPCM and healthy controls
- PPCMn = 67
- NPCMn = 31reference
- Healthy peripartumn = 10
- Healthy nonperipartumn = 10
- Outcome
- Serum proteome
Methodological detailsaptamer-based proteomic analysis (SomaScan 7K)
- Aptamer-based proteomic analysis (SomaScan 7K)
Main finding
As reported in the abstract
- Unique clustering of each patient group on principal component analysis
- P for difference <0.001
- Specific dysregulation of inflammatory pathways in PPCM vs NPCM, incl. upregulation of the cholesterol metabolism-related anti-inflammatory LXR/RXR pathway
- P < 0.01, Z-score 1.9-2.1
Further findings
Cardiac recovery in PPCM · 12 months
- Associated with downregulation of pro-inflammatory pathways and upregulation of LXR/RXR and PPARα/RXRα signaling
Original publication
Serum Proteomic Analysis of Peripartum Cardiomyopathy Reveals Distinctive Dysregulation of Inflammatory and Cholesterol Metabolism Pathways. JACC Heart Fail. Published 2 August 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →